Drug Shortage Report for TELMISARTAN
| Report ID | 223276 |
| Drug Identification Number | 02388944 |
| Brand name | TELMISARTAN |
| Common or Proper name | TELMISARTAN |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TELMISARTAN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-24 |
| Estimated end date | 2024-06-21 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-04-15 | French | Compare |
| v3 | 2024-04-15 | English | Compare |
| v2 | 2024-03-25 | French | Compare |
| v1 | 2024-03-25 | English | Compare |
Showing 1 to 4 of 4